Part 4
Human Immunodeficiency Virus (Hiv)

Chapters

1
Definitions
Section 120775
1.5
State Hiv Prevention and Education Funds
Sections 120780–120780.5
2
California Acquired Immune Deficiency Syndrome (Aids) Program (Cap)
Sections 120800–120871
3
Acquired Immune Deficiency Syndrome (Aids) Information
Sections 120875–120895
4
Acquired Immune Deficiency Syndrome (Aids) Early Intervention Projects
Sections 120900–120920
5
Provision of Azidothymidine
Sections 120925–120935
6
Human Immunodeficiency Virus (Hiv) Treatment
Sections 120950–120971
6.1
Human Immunodeficiency Virus (Hiv) Prevention
Sections 120972–120972.2
6.2
Hiv Care Program
Sections 120973–120974
7
Mandated Blood Testing and Confidentiality to Protect Public Health
Sections 120975–121023
8
Acquired Immune Deficiency Syndrome (Aids) Public Health Records Confidentiality Act
Sections 121025–121035
9
Acquired Immune Deficiency Syndrome (Aids) Public Safety and Testing Disclosure
Sections 121050–121070
10
Acquired Immune Deficiency Syndrome (Aids) Research Confidentiality Act
Sections 121075–121125
11
Acquired Immune Deficiency Syndrome (Aids) Research and Workshop Grants
Sections 121150–121180
12
Acquired Immune Deficiency Syndrome (Aids) Vaccine Research and Development Grant Program
Sections 121200–121225
13
Acquired Immune Deficiency Syndrome (Aids) Immunization
Sections 121250–121281
13.5
Disease Prevention Demonstration Project
13.6
Public Health Demonstration Projects
Sections 121287–121289
13.7
Statewide African-american Initiative
Sections 121290–121290.9
13.8
Hiv and Aging Demonstration Projects
Section 121295
14
Acquired Immune Deficiency Syndrome (Aids) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (Hiv) Infection
Sections 121300–121335
15
Hiv Reporting Systems
Section 121340
16
Therapeutic Monitoring Program
Section 121345
17
Pre- and Post-exposure Prophylaxis
Sections 121348–121348.4
18
Clean Needle and Syringe Exchange Program
Sections 121349–121349.3